These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30143536)

  • 1. Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma.
    Witt K; Ligtenberg MA; Conti L; Lanzardo S; Ruiu R; Wallmann T; Tufvesson-Stiller H; Chambers BJ; Rolny C; Lladser A; Lundqvist A; Cavallo F; Kiessling R
    Cancer Immunol Res; 2018 Nov; 6(11):1417-1425. PubMed ID: 30143536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prime-boost vaccination with plasmid and adenovirus gene vaccines control HER2/neu+ metastatic breast cancer in mice.
    Wang X; Wang JP; Rao XM; Price JE; Zhou HS; Lachman LB
    Breast Cancer Res; 2005; 7(5):R580-8. PubMed ID: 16168101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer.
    Lanzardo S; Conti L; Rooke R; Ruiu R; Accart N; Bolli E; Arigoni M; Macagno M; Barrera G; Pizzimenti S; Aurisicchio L; Calogero RA; Cavallo F
    Cancer Res; 2016 Jan; 76(1):62-72. PubMed ID: 26567138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of metastases with a Mage-b DNA vaccine in a mouse breast tumor model: potential for breast cancer therapy.
    Sypniewska RK; Hoflack L; Tarango M; Gauntt S; Leal BZ; Reddick RL; Gravekamp C
    Breast Cancer Res Treat; 2005 May; 91(1):19-28. PubMed ID: 15868428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA vaccination against neu reduces breast cancer incidence and metastasis in mice.
    Lachman LB; Rao XM; Kremer RH; Ozpolat B; Kiriakova G; Price JE
    Cancer Gene Ther; 2001 Apr; 8(4):259-68. PubMed ID: 11393278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cripto-1 as a novel therapeutic target for triple negative breast cancer.
    Castro NP; Fedorova-Abrams ND; Merchant AS; Rangel MC; Nagaoka T; Karasawa H; Klauzinska M; Hewitt SM; Biswas K; Sharan SK; Salomon DS
    Oncotarget; 2015 May; 6(14):11910-29. PubMed ID: 26059540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A therapeutic microparticle-based tumor lysate vaccine reduces spontaneous metastases in murine breast cancer.
    Gross BP; Wongrakpanich A; Francis MB; Salem AK; Norian LA
    AAPS J; 2014 Nov; 16(6):1194-203. PubMed ID: 25224145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cripto-1 vaccination elicits protective immunity against metastatic melanoma.
    Ligtenberg MA; Witt K; Galvez-Cancino F; Sette A; Lundqvist A; Lladser A; Kiessling R
    Oncoimmunology; 2016 May; 5(5):e1128613. PubMed ID: 27467944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein.
    Huang X; Wong MK; Yi H; Watkins S; Laird AD; Wolf SF; Gorelik E
    Cancer Res; 2002 Oct; 62(20):5727-35. PubMed ID: 12384531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MTDH/AEG-1-based DNA vaccine suppresses lung metastasis and enhances chemosensitivity to doxorubicin in breast cancer.
    Qian BJ; Yan F; Li N; Liu QL; Lin YH; Liu CM; Luo YP; Guo F; Li HZ
    Cancer Immunol Immunother; 2011 Jun; 60(6):883-93. PubMed ID: 21400023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A DNA vaccine targeting Fos-related antigen 1 enhanced by IL-18 induces long-lived T-cell memory against tumor recurrence.
    Luo Y; Zhou H; Mizutani M; Mizutani N; Liu C; Xiang R; Reisfeld RA
    Cancer Res; 2005 Apr; 65(8):3419-27. PubMed ID: 15833877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice.
    Sakai Y; Morrison BJ; Burke JD; Park JM; Terabe M; Janik JE; Forni G; Berzofsky JA; Morris JC
    Cancer Res; 2004 Nov; 64(21):8022-8. PubMed ID: 15520211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity.
    Garcia-Hernandez Mde L; Gray A; Hubby B; Klinger OJ; Kast WM
    Cancer Res; 2008 Feb; 68(3):861-9. PubMed ID: 18245488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mage-b vaccine delivered by recombinant Listeria monocytogenes is highly effective against breast cancer metastases.
    Kim SH; Castro F; Gonzalez D; Maciag PC; Paterson Y; Gravekamp C
    Br J Cancer; 2008 Sep; 99(5):741-9. PubMed ID: 18728665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA vaccines targeting tumor antigens to B7 molecules on antigen-presenting cells induce protective antitumor immunity and delay onset of HER-2/Neu-driven mammary carcinoma.
    Sloots A; Mastini C; Rohrbach F; Weth R; Curcio C; Burkhardt U; Jäger E; Forni G; Cavallo F; Wels WS
    Clin Cancer Res; 2008 Nov; 14(21):6933-43. PubMed ID: 18980988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice.
    Rovero S; Amici A; Di Carlo E; Bei R; Nanni P; Quaglino E; Porcedda P; Boggio K; Smorlesi A; Lollini PL; Landuzzi L; Colombo MP; Giovarelli M; Musiani P; Forni G
    J Immunol; 2000 Nov; 165(9):5133-42. PubMed ID: 11046045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surrogate tumor antigen vaccination induces tumor-specific immunity and the rejection of spontaneous metastases.
    Lewis JD; Shearer MH; Kennedy RC; Bright RK
    Cancer Res; 2005 Apr; 65(7):2938-46. PubMed ID: 15805297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local delivery of recombinant vaccinia virus encoding for neu counteracts growth of mammary tumors more efficiently than systemic delivery in neu transgenic mice.
    Masuelli L; Marzocchella L; Focaccetti C; Lista F; Nardi A; Scardino A; Mattei M; Turriziani M; Modesti M; Forni G; Schlom J; Modesti A; Bei R
    Cancer Immunol Immunother; 2010 Aug; 59(8):1247-58. PubMed ID: 20364378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Cripto-1 as a target for a cancer vaccine: WO2008040759.
    Bianco C; Salomon DS
    Expert Opin Ther Pat; 2009 Feb; 19(2):141-4. PubMed ID: 19441915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA vaccination with CD44 variant isoform reduces mammary tumor local growth and lung metastasis.
    Wallach-Dayan SB; Rubinstein AM; Hand C; Breuer R; Naor D
    Mol Cancer Ther; 2008 Jun; 7(6):1615-23. PubMed ID: 18566232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.